MAPLE PLACE (APPLEDORE) LIMITED
Company number 13951000 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MAPLE PLACE (APPLEDORE) LIMITED - Analysis Report
Company Number: 13951000
Analysis Date: 2025-07-20 14:01 UTC
Financial Health Assessment for MAPLE PLACE (APPLEDORE) LIMITED
1. Financial Health Score: D
Explanation:
The company is currently dormant with minimal financial activity reflected in its accounts. While dormancy itself is not a negative health indicator, the very low cash balance and total equity suggest a fragile financial state with limited operational activity or financial resources. This places the company in a cautious category, as it currently shows no signs of active business growth or revenue generation.
2. Key Vital Signs
| Metric | Value (2024) | Interpretation |
|---|---|---|
| Cash Balance | £6 | Critically low cash on hand, indicating no operational liquidity. |
| Total Assets Less Current Liabilities | £6 | Minimal net assets, showing negligible operational scale or financial buffer. |
| Shareholders' Funds (Equity) | £6 | Equity has decreased from £100 in previous years, signalling no capital injection or retained earnings. |
| Company Status | Dormant | No significant trading or financial transactions during the year. |
| Account Category | Dormant | Simplified reporting due to inactivity. |
| Directors | Six current directors appointed recently (since Sept 2023) | Indicates potential restructuring or preparatory phase for future operations. |
| Significant Control | Court Developments Limited owns 75-100% shares | Single controlling entity, likely managing the company’s strategic direction. |
3. Diagnosis
Underlying Business Health:
MAPLE PLACE (APPLEDORE) LIMITED is in a state of dormancy, meaning it has not conducted significant trading or financial activity since incorporation in 2022. Its financial statements confirm no income or expenses, no employees, and minimal assets. The drastic fall in cash from £100 to £6 suggests minor expenditure or asset adjustment but no incoming cash flow—much like a patient in a state of rest with no active symptoms but also no strengthening activity.
The recent appointment of multiple directors in late 2023 may indicate a strategic repositioning or preparation for future business activity. However, the company currently lacks the vital financial signs—such as positive cash flow, working capital, or retained earnings—that would demonstrate business viability or growth potential.
4. Recommendations
- Activate Business Operations: If the company intends to trade, initiate operational activities to generate cash flow and build working capital, akin to encouraging physical activity in a resting patient to build strength.
- Capital Injection: Consider equity funding or shareholder loans to replenish cash reserves and support initial expenses.
- Financial Monitoring: Implement routine financial controls and cash flow forecasts to detect early signs of distress or opportunity.
- Review Governance: Evaluate the role and effectiveness of the new directors in steering the company towards operational health.
- Compliance Maintenance: Ensure all filings (accounts, confirmation statements) continue to be submitted timely to avoid penalties and maintain good standing.
If the company remains dormant by choice, maintain minimal administrative costs and monitor the costs against potential benefits of dormancy.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.